Artificial intelligence is not fulfilling the “Do No Harm” principle in oncology: A mini review

While AI has the potential to revolutionize oncology care, there is growing evidence that it may be failing to adhere to the core principle of non-maleficence. This research article presents aspects in which the “ Do No Harm” principle in AI-driven oncology cannot be fulfilled yet. The authors have reviewed this scope on publications from the last five years 2020-2024. The study investigates how AI technologies have not aligned yet with the ethical imperative of non-maleficence across the cancer care domain. This mini-review acts as a summary of current reviews and involves analyzing articles published in each year of the last five years. The research contributes to a comprehensive understanding of current gaps in not applying the “Do No Harm” principle in AI-driven solutions for cancer patients and medical professionals. Results offer recommendations for healthcare providers, oncologists, policymakers, and developers to highlight the need for careful oversight ethical considerations, and safe integration into clinical practice in the future.